Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of STEAP1- and STEAP2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Tissue Factor-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of CD38-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of TROP-2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Nectin-4-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of B7-H4-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Her3-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of IGF-1R- and IGF-1 Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of c-Met-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...